Company · CIK 0001412067
Cascadian Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ACascadian Therapeutics, Inc.0001140361-18-017853 · 117.2 KBSEC(opens sec.gov)
- SC 13D/ACascadian Therapeutics, Inc.0001072613-18-000224 · 95.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-18-077500 · 27.6 KBSEC(opens sec.gov)
- 10-KAnnual report0001193125-18-075320 · 10.8 MBSEC(opens sec.gov)
- SC 13D/ACascadian Therapeutics, Inc.0001072613-18-000177 · 425.4 KBSEC(opens sec.gov)
- SC 13G/ACascadian Therapeutics, Inc.0001140361-18-007143 · 117.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-18-034805 · 67.7 KBSEC(opens sec.gov)
- SC 13G/ACascadian Therapeutics, Inc.0000038777-18-000053 · 196.0 KBSEC(opens sec.gov)
- SC 13GCascadian Therapeutics, Inc.0000215457-18-004559 · 13.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-18-026357 · 568.5 KBSEC(opens sec.gov)
Insiders
- Ayer Capital Management, LP10% Owner
- Azelby RobertDirector
- BARRIS PETER J10% Owner
- BASKETT FOREST10% Owner
- BIOTECHNOLOGY VALUE FUND L P10% Owner
- Biotechnology Value Trading Fund OS LP10% Owner
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.10% Owner
- Christianson GaryChief Operating Officer
Tickers
No tickers on record.
Addresses
business
3101 WESTERN AVE. SUITE 600
SEATTLE, WA, 98121
mailing
3101 WESTERN AVE. SUITE 600
SEATTLE, WA, 98121
Former names
- Oncothyreon Inc.2016-06-09
- Biomira CORP2007-09-27
Same industry
Related Services-Commercial Physical & Biological Research companies
View all Services-Commercial Physical & Biological Research companies